88 related articles for article (PubMed ID: 24713258)
1. [Research progress of relationship between HMGA2 and tumors].
Qin Y; Niu Y; Liu F
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):65-7. PubMed ID: 24713258
[No Abstract] [Full Text] [Related]
2. High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia.
Unachukwu U; Chada K; D'Armiento J
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365712
[TBL] [Abstract][Full Text] [Related]
3. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
4. Oncological role of HMGA2 (Review).
Zhang S; Mo Q; Wang X
Int J Oncol; 2019 Oct; 55(4):775-788. PubMed ID: 31432151
[TBL] [Abstract][Full Text] [Related]
5. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition.
Thuault S; Valcourt U; Petersen M; Manfioletti G; Heldin CH; Moustakas A
J Cell Biol; 2006 Jul; 174(2):175-83. PubMed ID: 16831886
[TBL] [Abstract][Full Text] [Related]
7. SiRNA-HMGA2 weakened AGEs-induced epithelial-to-mesenchymal transition in tubular epithelial cells.
Bai YH; Wang JP; Yang M; Zeng Y; Jiang HY
Biochem Biophys Res Commun; 2015 Feb; 457(4):730-5. PubMed ID: 25623534
[TBL] [Abstract][Full Text] [Related]
8. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
9. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q
Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062
[TBL] [Abstract][Full Text] [Related]
10. Identification of the benign mesenchymal tumor gene HMGA2 in lymphangiomyomatosis.
D'Armiento J; Imai K; Schiltz J; Kolesnekova N; Sternberg D; Benson K; Pardo A; Selman M; Smolarek T; Vundavalli M; Sonnet J; Szabolcs M; Chada K
Cancer Res; 2007 Mar; 67(5):1902-9. PubMed ID: 17332316
[TBL] [Abstract][Full Text] [Related]
11. Do cells let-7 determine stemness?
Dröge P; Davey CA
Cell Stem Cell; 2008 Jan; 2(1):8-9. PubMed ID: 18371414
[TBL] [Abstract][Full Text] [Related]
12. p14Arf acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis.
Markowski DN; Winter N; Meyer F; von Ahsen I; Wenk H; Nolte I; Bullerdiek J
Genes Chromosomes Cancer; 2011 Jul; 50(7):489-98. PubMed ID: 21456046
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma.
Liu W; Xu G; Liu H; Li T
FEBS Lett; 2015 Oct; 589(20 Pt B):3148-53. PubMed ID: 26341146
[TBL] [Abstract][Full Text] [Related]
14. Comment re: HMGA2 is a negative regulator of DNA-PK pathway.
Bullerdiek J; Rommel B
Cancer Res; 2010 Feb; 70(4):1742; author reply 1742. PubMed ID: 20145117
[No Abstract] [Full Text] [Related]
15. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
Motoyama K; Inoue H; Nakamura Y; Uetake H; Sugihara K; Mori M
Clin Cancer Res; 2008 Apr; 14(8):2334-40. PubMed ID: 18413822
[TBL] [Abstract][Full Text] [Related]
16. Rb protein is essential to the senescence-associated heterochromatic foci formation induced by HMGA2 in primary WI38 cells.
Shi X; Tian B; Liu L; Gao Y; Ma C; Mwichie N; Ma W; Han L; Huang B; Lu J; Zhang Y
J Genet Genomics; 2013 Aug; 40(8):391-8. PubMed ID: 23969248
[TBL] [Abstract][Full Text] [Related]
17. HMGA2: A pituitary tumour subtype-specific oncogene?
Fedele M; Palmieri D; Fusco A
Mol Cell Endocrinol; 2010 Sep; 326(1-2):19-24. PubMed ID: 20347930
[TBL] [Abstract][Full Text] [Related]
18. [Selection and anti-cancer effects of siRNAs targeting HMGA2 gene].
Wang QZ; Gong YH; Lü YH; Fei LN; Liu HJ; Diao Y; Xu RA
Yao Xue Xue Bao; 2011 Dec; 46(12):1444-50. PubMed ID: 22375416
[TBL] [Abstract][Full Text] [Related]
19. [The biological features and their roles of cancer stem cells in invasion and neovascularization of cancer].
Bian XW
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):505-6. PubMed ID: 20021957
[No Abstract] [Full Text] [Related]
20. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.
Fedele M; Visone R; De Martino I; Troncone G; Palmieri D; Battista S; Ciarmiello A; Pallante P; Arra C; Melillo RM; Helin K; Croce CM; Fusco A
Cancer Cell; 2006 Jun; 9(6):459-71. PubMed ID: 16766265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
